474 related articles for article (PubMed ID: 9436018)
1. [Clinical findings of neurogenic bladder in patients with Parkinson's disease, multiple sclerosis and spinocerebellar degeneration].
Shimizu K; Yasukawa M; Yamamoto M; Hirao Y; Momose H; Kashiwai H; Kawata Y; Yamada K
Hinyokika Kiyo; 1997 Nov; 43(11):765-9. PubMed ID: 9436018
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
[TBL] [Abstract][Full Text] [Related]
3. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
[TBL] [Abstract][Full Text] [Related]
4. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
Roth B; Studer UE; Fowler CJ; Kessler TM
J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
[TBL] [Abstract][Full Text] [Related]
5. Urological manifestations of chronic schistosomal myeloradiculopathy.
Gomes CM; Hisano M; Machado LR; Figueiredo JA; Lucon AM; Trigo-Rocha FE
BJU Int; 2005 Oct; 96(6):853-6. PubMed ID: 16153216
[TBL] [Abstract][Full Text] [Related]
6. Lower urinary tract dysfunction in Machado-Joseph disease: a study of 11 clinical-urodynamic observations.
Sakakibara R; Uchiyama T; Arai K; Yamanishi T; Hattori T
J Neurol Sci; 2004 Mar; 218(1-2):67-72. PubMed ID: 14759635
[TBL] [Abstract][Full Text] [Related]
7. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease.
Finazzi-Agrò E; Peppe A; D'Amico A; Petta F; Mazzone P; Stanzione P; Micali F; Caltagirone C
J Urol; 2003 Apr; 169(4):1388-91. PubMed ID: 12629368
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of the urologic consequences of neurologic disease.
Kotkin L; Milam DF
Tech Urol; 1996; 2(4):210-9. PubMed ID: 9085542
[TBL] [Abstract][Full Text] [Related]
9. [Difference between the clinical significance of Credé voiding and Valsalva voiding in the urological management of spina bifida patients].
Momose H; Kashiwai H; Kawata Y; Hirayama A; Hirata N; Yamada K; Yamamoto M; Hirao Y
Hinyokika Kiyo; 1997 Nov; 43(11):771-5. PubMed ID: 9436019
[TBL] [Abstract][Full Text] [Related]
10. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease.
Kabay SC; Kabay S; Yucel M; Ozden H
Neurourol Urodyn; 2009; 28(1):62-7. PubMed ID: 18837432
[TBL] [Abstract][Full Text] [Related]
11. Spinal cord injury in children: long-term urodynamic and urological outcomes.
Generao SE; Dall'era JP; Stone AR; Kurzrock EA
J Urol; 2004 Sep; 172(3):1092-4, discussion 1094. PubMed ID: 15311046
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation in 69 cases with neurogenic bladder].
Sasagawa M; Magome A; Kikuyama A; Kobayashi S; Kawamura K; Suzuki K; Tsugawa R
Hinyokika Kiyo; 1991 Feb; 37(2):123-8. PubMed ID: 1675545
[TBL] [Abstract][Full Text] [Related]
13. Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Stocchi F; Barbato L; Carbone A; Fabbrini G; Ruggieri S; Bonamartini A; Baffigo G; Agnoli A
Adv Neurol; 1993; 60():434-7. PubMed ID: 8420168
[No Abstract] [Full Text] [Related]
14. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
15. Relationship of bladder dysfunction to lesion site in multiple sclerosis.
Araki I; Matsui M; Ozawa K; Takeda M; Kuno S
J Urol; 2003 Apr; 169(4):1384-7. PubMed ID: 12629367
[TBL] [Abstract][Full Text] [Related]
16. Dysfunctional voiding in women.
Carlson KV; Rome S; Nitti VW
J Urol; 2001 Jan; 165(1):143-7; discussion 147-8. PubMed ID: 11125384
[TBL] [Abstract][Full Text] [Related]
17. Urinary dysfunction in multiple sclerosis.
Nakipoglu GF; Kaya AZ; Orhan G; Tezen O; Tunc H; Ozgirgin N; Ak F
J Clin Neurosci; 2009 Oct; 16(10):1321-4. PubMed ID: 19560927
[TBL] [Abstract][Full Text] [Related]
18. [Comparative assessment of combined therapy of neurogenic hyperactivity of detrusor in patients with Parkinson's disease].
Loran OB; Fedorova NV; Mazurenko DA; Khitarishvili EV
Urologiia; 2006; (2):37-9, 41. PubMed ID: 16708587
[TBL] [Abstract][Full Text] [Related]
19. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.
Amarenco G; Ismael SS; Even-Schneider A; Raibaut P; Demaille-Wlodyka S; Parratte B; Kerdraon J
J Urol; 2003 Jun; 169(6):2210-5. PubMed ID: 12771752
[TBL] [Abstract][Full Text] [Related]
20. [Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease].
Krivoborodov GG; Gekht AB; Korshunova ES
Urologiia; 2006; (4):3-6. PubMed ID: 17058670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
